Shi Chen

601 total citations
29 papers, 400 citations indexed

About

Shi Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Shi Chen has authored 29 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 6 papers in Surgery. Recurrent topics in Shi Chen's work include Gastric Cancer Management and Outcomes (11 papers), Metastasis and carcinoma case studies (8 papers) and Gastrointestinal Tumor Research and Treatment (6 papers). Shi Chen is often cited by papers focused on Gastric Cancer Management and Outcomes (11 papers), Metastasis and carcinoma case studies (8 papers) and Gastrointestinal Tumor Research and Treatment (6 papers). Shi Chen collaborates with scholars based in China, United States and South Korea. Shi Chen's co-authors include Yongming Chen, Yuanfang Li, Run‐Cong Nie, Shuqiang Yuan, Ying-Bo Chen, Xiao‐Jiang Chen, Lixin Liu, Xingliang Liu, Yanzi Yan and Zhiwei Zhou and has published in prestigious journals such as Journal of Clinical Oncology, Biomaterials and ACS Applied Materials & Interfaces.

In The Last Decade

Shi Chen

29 papers receiving 395 citations

Peers

Shi Chen

PRM

ONCOL

SURGE

GASTR

Haocheng Li Canada

Zachary E. Stiles United States

Xiao-Hai Song China

Sung Kim South Korea

Rodica Bîrlă Romania

Lin Shao China

A Bali Belgium

Maarten Anderegg Netherlands

Dong Il Kang South Korea

Xiujiang Yang China

Haocheng Li Canada

Shi Chen

129 ×0.6

PRM

125 ×1.0

ONCOL

91 ×0.9

SURGE

13 ×0.2

GASTR

74 ×1.3

Citations per year, relative to Shi Chen Shi Chen (= 1×) peers Haocheng Li

Countries citing papers authored by Shi Chen

Since Specialization

Citations

This map shows the geographic impact of Shi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Chen more than expected).

Fields of papers citing papers by Shi Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Chen. The network helps show where Shi Chen may publish in the future.

Co-authorship network of co-authors of Shi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shi Chen. A scholar is included among the top collaborators of Shi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi Chen. Shi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Shi, et al.. (2025). Inhalable Artificial Polymeric Nucleases Degrading Neutrophil Extracellular Trap‐DNAs and Alleviating Pulmonary Fibrosis. Advanced Science. 12(34). e05357–e05357. 1 indexed citations

Chen, Shi, et al.. (2025). Precise Oligopeptides Block CCDC25 Interaction with DNA in Neutrophil Extracellular Traps Inhibiting Tumor Metastasis. ACS Applied Materials & Interfaces. 17(10). 15208–15219. 2 indexed citations

Zhang, Ruopeng, Xiaojiang Chen, Guoming Chen, et al.. (2025). Novel surveillance protocol for gastric cancer based on CEA: a high-volume multi-center study. BMC Cancer. 25(1). 1396–1396. 1 indexed citations

Zhao, Ting, et al.. (2025). The level of moral sensitivity among nurses: a systematic review and meta-analysis. BMC Nursing. 24(1). 321–321. 1 indexed citations

Zeng, Zhipeng, Shi Chen, Haolin Chen, et al.. (2024). Di-PEGylated insulin: A long-acting insulin conjugate with superior safety in reducing hypoglycemic events. Acta Pharmaceutica Sinica B. 14(6). 2761–2772. 7 indexed citations

Guo, Xinyu, Shi Chen, Xueyan Wang, & Xiaowei Liu. (2023). Immune-related pulmonary toxicities of checkpoint inhibitors in non-small cell lung cancer: Diagnosis, mechanism, and treatment strategies. Frontiers in Immunology. 14. 1138483–1138483. 15 indexed citations

Liu, Xingliang, Shi Chen, Lixin Liu, & Yongming Chen. (2023). Cationic brush hybrid nanoparticles scavenge cell-free DNA to enhance rheumatoid arthritis treatment. Acta Biomaterialia. 170. 215–227. 4 indexed citations

Zeng, Zhipeng, Shi Chen, & Yongming Chen. (2023). Zwitterionic Polymer: A New Paradigm for Protein Conjugation beyond PEG. ChemMedChem. 18(20). e202300245–e202300245. 16 indexed citations

Liu, Xingliang, Shi Chen, Yanzi Yan, Lixin Liu, & Yongming Chen. (2022). Nanoparticulate DNA scavenger loading methotrexate targets articular inflammation to enhance rheumatoid arthritis treatment. Biomaterials. 286. 121594–121594. 48 indexed citations

10.

Li, Fajiu, Chenghong Li, Shi Chen, et al.. (2022). The earlier, the better? A review of neoadjuvant immunotherapy in resectable non‐small‐cell lung cancer. Chronic Diseases and Translational Medicine. 8(2). 100–111. 5 indexed citations

11.

Kim, Jin Won, Jie Zhou, Man Nie, et al.. (2021). Adjuvant Chemotherapy for Gastric Cancer Patients with Mismatch Repair Deficiency or Microsatellite Instability: Systematic Review and Meta-Analysis. Annals of Surgical Oncology. 29(4). 2324–2331. 21 indexed citations

12.

Nie, Run‐Cong, Yun Wang, Shuqiang Yuan, et al.. (2021). Association Between Body Mass Index and Survival Outcomes In Patients Treated With Immune Checkpoint Inhibitors: Meta-analyses of Individual Patient Data. Journal of Immunotherapy. 44(9). 371–375. 16 indexed citations

13.

Chen, Xiao‐Jiang, Shuqiang Yuan, Jin‐Ling Duan, et al.. (2020). The Value of PD-L1 Expression in Predicting the Efficacy of Anti-PD-1 or Anti-PD-L1 Therapy in Patients with Cancer: A Systematic Review and Meta-Analysis. Disease Markers. 2020. 1–14. 22 indexed citations

14.

Nie, Run‐Cong, Shuqiang Yuan, Yuanfang Li, et al.. (2019). Risk-stratification model to select conversion surgery for advanced gastric cancer patients. Chinese Journal of Cancer Research. 31(1). 178–187. 7 indexed citations

15.

Wang, Zhengli, Li Liu, Xiaoyu Hu, et al.. (2019). Probiotics may not prevent the deterioration of necrotizing enterocolitis from stage I to II/III. BMC Pediatrics. 19(1). 185–185. 7 indexed citations

16.

Nie, Run‐Cong, Shuqiang Yuan, Ying-Bo Chen, et al.. (2019). Robust Immunoscore Model to Predict the Response to Anti-PD1 Therapy in Melanoma. SSRN Electronic Journal. 1 indexed citations

17.

Nie, Run‐Cong, Shuqiang Yuan, Shi Chen, et al.. (2018). Bursectomy for advanced gastric cancer: an update meta-analysis. World Journal of Surgical Oncology. 16(1). 66–66. 10 indexed citations

18.

Chen, Shi, Run‐Cong Nie, Yuanfang Li, et al.. (2017). Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination. World Journal of Surgical Oncology. 15(1). 52–52. 20 indexed citations

19.

Nie, Run‐Cong, Shuqiang Yuan, Xiao‐Jiang Chen, et al.. (2017). Endoscopic ultrasonography compared with multidetector computed tomography for the preoperative staging of gastric cancer: a meta-analysis. World Journal of Surgical Oncology. 15(1). 113–113. 36 indexed citations

20.

Nie, Run‐Cong, Shuqiang Yuan, Yuanfang Li, et al.. (2017). Clinicopathological Characteristics and Prognostic Value of Signet Ring Cells in Gastric Carcinoma: A Meta-Analysis. Journal of Cancer. 8(17). 3396–3404. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact